With rider, diabetics get cover from Day 1

Individuals suffering from diabetes can now get health insurance coverage from the first day after paying a rider premium. These special plans do not have the usual three-year waiting period for both type 1 and type 2 diabetes and cover those with high HbA1c levels up to 10 or those even on insulin therapy, depending upon the underwriting.

These specialised health insurance plans for people with diabetes provide comprehensive coverage tailored to their specific needs, including regular doctor visits, medications, and preventive care, without the exclusions found in standard policies. While other illnesses or diseases not-related to diabetes are also covered under these plans, there may be a waiting period up to a year.

Siddharth Singhal, head, Health Insurance, Policybazaar.com, says conditions associated with diabetes such as renal failure, cardiovascular diseases, and diabetic retinopathy are covered from day 1 under the specialised coverage plans. “OPD benefits include diagnostic tests, doctor visits, and medicines for diabetes-related conditions,” he says.

Also Read CDSCO gives nod to Cipla for distribution and marketing of inhaled insulin in India How to manage Chronic Kidney Disease in winter season? How to maintain healthy vitamin D levels in winter and low-sunlight conditions? Limited premium plan easier on the pocket

Also ReadGovt has asked nationalised banks to prematurely retire underperforming employees? Here’s what FinMin says

Day 1 riders for diabetes are different from the pre-existing disease reduction riders, which reduce the standard waiting period for pre-existing conditions like diabetes from 3-4 years to around one year. Other health insurance riders are not linked to pre-existing conditions (PED) and focus on additional benefits like OPD, critical illness protection, or consumables cover.
Before the introduction of Day 1 riders, policyholders with diabetes had an option to choose PED reduction riders which offered partial relief by reducing the waiting period from 3-4 years to one year. Diabetes-related claims couldn’t be made during the first year of the policy. This gap often left individuals with high diabetes exposed to significant medical expenses. The introduction of Day 1 riders has resolved this issue by providing immediate coverage, ensuring policyholders are financially protected from the start.

Disclose details

People with diabetes should disclose this when choosing a health plan. They must select a plan offering cashless hospitalisation. A policy with lower sum insured may not fully cover expensive treatments like dialysis or surgeries. 

 » Read More

Related Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s